Descriptor English: | Zoledronic Acid | ||||||
Descriptor Spanish: |
Ácido Zoledrónico
| ||||||
Descriptor Portuguese: | Ácido Zoledrônico | ||||||
Descriptor French: | Acide zolédronique | ||||||
Entry term(s): |
2-(Imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid CGP 42'446 CGP 42446 CGP 42446A CGP-42'446 CGP-42446 CGP42'446 CGP42446 Zoledronate Zoledronic Acid Anhydrous Zometa |
||||||
Tree number(s): |
D02.705.429.500.942 D03.383.129.308.990 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077211 | ||||||
Scope note: | An imidobisphosphonate inhibitor of BONE RESORPTION that is used for the treatment of malignancy-related HYPERCALCEMIA; OSTEITIS DEFORMANS; and OSTEOPOROSIS. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Bone Density Conservation Agents |
||||||
Registry Number: | 6XC1PAD3KF | ||||||
Public MeSH Note: | 2019; ZOLEDRONIC ACID was indexed under DIPHOSPHONATES and IMIDAZOLES 1994-2018 |
||||||
History Note: | 2019 (1994) |
||||||
DeCS ID: | 57546 | ||||||
Unique ID: | D000077211 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2019/07/05 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Zoledronic Acid
- Preferred
CGP 42446A
- Narrower
Zometa
- Narrower
Zoledronic Acid Anhydrous
- Narrower
Zoledronate
- Narrower
Concept UI |
M0234600 |
Scope note | An imidobisphosphonate inhibitor of BONE RESORPTION that is used for the treatment of malignancy-related HYPERCALCEMIA; OSTEITIS DEFORMANS; and OSTEOPOROSIS. |
Preferred term | Zoledronic Acid |
Entry term(s) |
2-(Imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid |
Concept UI |
M0326639 |
Preferred term | CGP 42446A |
Entry term(s) |
CGP 42'446 CGP 42446 CGP-42'446 CGP-42446 CGP42'446 CGP42446 |
Concept UI |
M0397726 |
Preferred term | Zometa |
Concept UI |
M0234599 |
Preferred term | Zoledronic Acid Anhydrous |
Concept UI |
M000637179 |
Preferred term | Zoledronate |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey